Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration
View ORCID ProfileThomas M Hallam, Emanuela Gardenal, Fraser McBlane, GaEun Cho, Lucy Lee Ferraro, Eva Pekle, Darlene Lu, Kate Carney, Claire Wenden, Hannah Beadsmoore, Sergio Kaiser, Lauren Drage, Thomas Haye, Iris Kassem, Nalini Rangaswamy, Ma’en Obeidat, Cyndy Grosskreutz, Magali Saint-Geniez, David H Steel, Robert E MacLaren, Scott Ellis, Claire L Harris, Stephen Poor, Amy V Jones FOCUS Principal Investigators
doi: https://doi.org/10.1101/2024.06.12.24308796
Thomas M Hallam
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
2Translational Research, Ophthalmology, BioMedical Research, Novartis, United Kingdom
Emanuela Gardenal
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
2Translational Research, Ophthalmology, BioMedical Research, Novartis, United Kingdom
Fraser McBlane
3Pharmacokinetic Sciences, Translational Medicine, BioMedical Research, Novartis, Switzerland
GaEun Cho
4Clinical Development, Global Drug Development, Novartis, United States
Lucy Lee Ferraro
5Clinical Development, Global Drug Development, Novartis, Switzerland
Eva Pekle
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
6Biomarker Development, Translational Medicine, BioMedical Research, Novartis, United Kingdom
Darlene Lu
7Biostatistics, Global Drug Development, Novartis, United States
Kate Carney
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
8Pharmacokinetic Sciences, Translational Medicine, BioMedical Research, Novartis, United Kingdom
Claire Wenden
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
8Pharmacokinetic Sciences, Translational Medicine, BioMedical Research, Novartis, United Kingdom
Hannah Beadsmoore
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
8Pharmacokinetic Sciences, Translational Medicine, BioMedical Research, Novartis, United Kingdom
Sergio Kaiser
9Biomarker Development, Translational Medicine, BioMedical Research, Novartis, Switzerland
Lauren Drage
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
10Cell and Gene Therapies, Technical Research and Development, Novartis, United Kingdom
Thomas Haye
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
10Cell and Gene Therapies, Technical Research and Development, Novartis, United Kingdom
Iris Kassem
11Ophthalmology, Translational Medicine, BioMedical Research, Novartis, United States
Nalini Rangaswamy
11Ophthalmology, Translational Medicine, BioMedical Research, Novartis, United States
Ma’en Obeidat
12Biomarker Development, Translational Medicine, BioMedical Research, Novartis, United States
Cyndy Grosskreutz
13Translational Research, Ophthalmology, BioMedical Research, Novartis, United States
Magali Saint-Geniez
13Translational Research, Ophthalmology, BioMedical Research, Novartis, United States
David H Steel
14Bioscience Institute, Newcastle University, Newcastle Upon Tyne, UK; Sunderland Eye Infirmary, Sunderland, United Kingdom
Robert E MacLaren
15Nuffield Laboratory of Ophthalmology and Oxford Eye Hospital, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Scott Ellis
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
2Translational Research, Ophthalmology, BioMedical Research, Novartis, United Kingdom
Claire L Harris
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
2Translational Research, Ophthalmology, BioMedical Research, Novartis, United Kingdom
Stephen Poor
4Clinical Development, Global Drug Development, Novartis, United States
Amy V Jones
1Gyroscope Therapeutics Ltd, A Novartis Company, United Kingdom
6Biomarker Development, Translational Medicine, BioMedical Research, Novartis, United Kingdom
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted November 28, 2024.
Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration
Thomas M Hallam, Emanuela Gardenal, Fraser McBlane, GaEun Cho, Lucy Lee Ferraro, Eva Pekle, Darlene Lu, Kate Carney, Claire Wenden, Hannah Beadsmoore, Sergio Kaiser, Lauren Drage, Thomas Haye, Iris Kassem, Nalini Rangaswamy, Ma’en Obeidat, Cyndy Grosskreutz, Magali Saint-Geniez, David H Steel, Robert E MacLaren, Scott Ellis, Claire L Harris, Stephen Poor, Amy V Jones
medRxiv 2024.06.12.24308796; doi: https://doi.org/10.1101/2024.06.12.24308796
Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration
Thomas M Hallam, Emanuela Gardenal, Fraser McBlane, GaEun Cho, Lucy Lee Ferraro, Eva Pekle, Darlene Lu, Kate Carney, Claire Wenden, Hannah Beadsmoore, Sergio Kaiser, Lauren Drage, Thomas Haye, Iris Kassem, Nalini Rangaswamy, Ma’en Obeidat, Cyndy Grosskreutz, Magali Saint-Geniez, David H Steel, Robert E MacLaren, Scott Ellis, Claire L Harris, Stephen Poor, Amy V Jones
medRxiv 2024.06.12.24308796; doi: https://doi.org/10.1101/2024.06.12.24308796
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (205)
- Cardiovascular Medicine (2966)
- Dermatology (251)
- Emergency Medicine (445)
- Epidemiology (12797)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4616)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2940)
- Health Policy (1072)
- Hematology (393)
- HIV/AIDS (931)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4396)
- Nursing (238)
- Nutrition (646)
- Oncology (2288)
- Ophthalmology (651)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (6988)
- Radiology and Imaging (1541)
- Respiratory Medicine (919)
- Rheumatology (444)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)